Back

High-sensitivity troponin is a biomarker of medium term mortality in 20,000 consecutive hospital patients undergoing a blood test for any reason

26 August 2022 (14:30 - 14:40)
Organised by:
Congress Presentation Part of: Troponin and other biomarkers in acute coronary syndromes Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Jonathan Hinton

University Dorset Hospital, Bournemouth (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Extending the no objective testing rules to patients triaged by the ESC 0/1-hour algorithms
Doctor J. Boeddinghaus (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Cardiac troponin elevation and mortality in takotsubo syndrome: new insights from the international takotsubo (InterTAK) registry
Professor B. Stahli (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Impact of time from symptom onset on the diagnostic performance of high-sensitivity cardiac troponin for type 1 myocardial infarction
Doctor M. Lowry (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Implementation of high-sensitivity cardiac troponin and risk of myocardial infarction or death at 5 years: a stepped-wedge cluster-randomised controlled trial
Doctor K. Lee (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial
Doctor K. Jering (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Troponin and other biomarkers in acute coronary syndromes

The Event

Event poster

ESC Congress 2022

26 August 2022 14:30 CET
You may be interested in
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers
thumbnail
Congress Presentation
Implementing cardiac biomarkers in clinical practice: insights from risk stratification with high-sensitivity troponin in asymptomatic individuals
thumbnail
Congress Presentation
The utility of cardiac troponin as a monitoring and risk stratification tool in cardiovascular disease prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources